38 results
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
28 Jun 24
Departure of Directors or Certain Officers
5:00pm
to, a crime constituting a felony or conviction in respect of, or plea of no contest to, any act involving fraud, dishonesty or moral turpitude, (iii
10-K
2023 FY
EX-31.2
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, summarize and report financial information; and
Any fraud, whether or not material, that involves management or other employees who have a significant
10-K
qiire9x1r0o6
1 Apr 24
Annual report
7:00am
10-K
EX-31.1
t1dm2 1phl
1 Apr 24
Annual report
7:00am
8-K
831mljy
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
10-Q
EX-31.2
ezah8k
15 Sep 23
Quarterly report
4:45pm
10-Q
EX-31.1
gp6 k7lt040
15 Sep 23
Quarterly report
4:45pm
10-Q
ujkdyvipcw 2htl
15 Sep 23
Quarterly report
4:45pm
8-K
EX-1.1
0jrzd8r6 oc1sbh
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
424B4
gx6peap89 w9f
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
bttmfiitkt 6ky7
4 Aug 23
Prospectus with pricing info
12:59pm